Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Chronic liver disease |Cirrhosis |Alkaline phosphatase (ALP) |Liver Function Tests |Ascites Assessment and Management |Budd-Chiari syndrome |Autoimmune Hepatitis |Primary Biliary Cirrhosis |Primary Sclerosing Cholangitis |Wilson disease |Hereditary Haemochromatosis |Alpha-1 Antitrypsin (AAT) deficiency |Non alcoholic steatohepatitis (NASH) |Spontaneous Bacterial Peritonitis |Alcoholism and Alcoholic Liver Disease
These are not tests of liver function but liver damage or cholestasis. Normal LFTs does not mean a normal liver. The three main causes of an acute and severe derangement of all liver enzymes are hepatic ischaemia, viruses or drugs/toxins
Test | Usefulness |
---|---|
Aspartate Aminotransferase (AST) | Elevation often indicates liver damage, especially in alcoholic liver disease. AST is less specific than ALT for liver injury and can be elevated in conditions affecting other organs, like muscle or heart. |
Alanine Aminotransferase (ALT) | ALT is more specific to the liver than AST. Elevated levels suggest hepatocellular injury, such as viral hepatitis or non-alcoholic fatty liver disease. |
Alkaline Phosphatase (ALP) | ALP elevation suggests cholestasis or bile duct obstruction. It can also be elevated in bone disease, so liver-specific isoenzymes or GGT may be used to confirm liver origin. |
Gamma-Glutamyl Transferase (GGT) | GGT is often elevated in cholestasis and can confirm that elevated ALP is of hepatic origin. It is also sensitive to alcohol intake and can be elevated in alcoholic liver disease. |
Bilirubin (Total and Direct) | Total bilirubin includes both direct (conjugated) and indirect (unconjugated) bilirubin. Elevated bilirubin causes jaundice and can indicate hepatocellular injury, cholestasis, or haemolysis. Direct bilirubin elevation suggests hepatobiliary disease. |
Albumin | Albumin is a protein produced by the liver. Low levels can indicate chronic liver disease, especially cirrhosis, and can contribute to edema and ascites. However, albumin levels can also be low in other conditions, such as nephrotic syndrome. |
Prothrombin Time (PT) and INR | These tests measure the time it takes for blood to clot and can be prolonged in liver disease due to impaired production of clotting factors. They are useful in assessing the severity of liver dysfunction and in monitoring anticoagulation therapy. |
Platelet Count | Thrombocytopenia (low platelet count) can be a sign of portal hypertension and splenomegaly in cirrhosis. It can also result from bone marrow suppression in chronic liver disease. |
Alpha-Fetoprotein (AFP) | AFP is a tumour marker that can be elevated in hepatocellular carcinoma (HCC) and is often used to monitor patients with chronic liver disease at risk of developing HCC. |
Ammonia | Elevated ammonia levels can occur in hepatic encephalopathy, a serious complication of advanced liver disease, due to the liver's inability to detoxify ammonia from the blood. |
Liver Biopsy | Histological examination of liver tissue can provide definitive information about the type and extent of liver disease, including staging of fibrosis in chronic liver diseases. |
FibroScan (Transient Elastography) | A non-invasive test that measures liver stiffness to assess the degree of fibrosis and cirrhosis. It is useful in monitoring chronic liver diseases and avoiding the need for liver biopsy. |
Imaging Studies (Ultrasound, CT, MRI) | Imaging is used to assess liver size, shape, and structure, detect masses, assess bile ducts, and identify complications such as ascites, portal hypertension, and hepatic vein thrombosis. |
Liver Disease | Abnormal test | Diagnostic test |
---|---|---|
Autoimmune hepatitis | Elevated AST and ALT | ANA anti-smooth muscle ab |
Primary biliary cirrhosis | Elevated ALP | Antimitochondrial antibody |
Alcoholic liver disease | AST/ALT >2 | Improves with abstention |
Primary sclerosing cholangitis | Raised ALP | MRCP pANCA |
Haemochromatosis | Elevated AST and ALT | Ferritin, Genetic Analysis |
Alpha-2 antitrypsin | Elevated AST and ALT | Phenotype analysis |
Wilson's disease | Elevated AST and ALT | ALP low, Ceruloplasmin low, High urine copper, High liver copper |
Hepatitis A | Elevated AST and ALT | Anti HAV IgM |
Hepatitis B | Elevated AST and ALT | HbSAg, Anti HBc IgM, HbeAg, HBVDNA |
Hepatitis C | Elevated AST and ALT | Anti HCV, HCV RNA |